Session 5 Evaluation: CMHC - Taming the Flames: Inflammation in Cardiometabolic Disease

Please follow the steps below for direct access to the evaluation for CMHC's Spring Meeting (Session 5: Taming the Flames: Inflammation in Cardiometabolic Disease) 


In order to access this evaluation form, you must first REGISTER or login on this website. Please note this is a separate site from To begin registration steps:

  1. Click on the Register/Take Course tab on this page and follow the instructions.
  2. Once the above step is complete you will be able to access the evaluation starting on Saturday, May 20 at 3:00pm EDT by clicking on the Register tab of this page. Please note this website will refer to this as a "Course", please disregard this. Once you are registered, you will have direct access to the evaluation survey to claim your credits. 

The evaluation will be available on Saturday, May 20, 2023 at 3:00pm EDT.  Evaluations must be completed by Wednesday, May 31, 2023 at 11:59 pm EDT. Upon completion of the CME/CE evaluation, attendees can download their Session 5 certificate.

Target Audience

The educational design of this activity addresses the needs of US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals involved in the management and treatment of cardiometabolic patients.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Discuss the interrelationships among inflammation & cardiometabolic risk factors, as well as the role of inflammation on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease.
  • Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease.
  • Outline strategies aimed at timely screening and prevention of cardiometabolic disease, including assessment of risk factors and biomarkers, and lifestyle modifications.
  • Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences in order to optimize outcomes.
  • Summarize recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field.
Course summary
Available credit: 
  • 9.25 ACPE Pharmacy
  • 9.25 AMA PRA Category 1 Credit
  • 9.25 ANCC
  • 9.25 CDE
  • 9.25 Participation
Course opens: 
Course expires: 

Session 5: Taming the Flames: Inflammation in Cardiometabolic Disease

May 19-20, 2023 at the Gaylord Palms, Orlando, FL


PACE LogoPicture1Cmhc Logo Color Lg

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Cardiometabolic Health Congress (CMHC).  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PACE designates this live activity for a maximum of 9.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The maximum number of hours awarded for this Continuing Nursing Education activity is 9.25 contact hours.

Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.

PACE designates this continuing education activity for 9.25 contact hour(s) (0.925 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA4008073-9999-23-145-L01-P. Type of activity: Application

This program offers 9.25 CPEUs for dietitians.

There is a registration fee for participating and receiving CME/CE credit for this educational activity. Registration information can be found here.


Learners may earn up to a maximum of 9.25 AMA/ACPE/ANCC/CDR credits for attending the meeting. Evaluations are accessible at the end of the meeting at 3:00pm Saturday, May 20, 2023 and must be completed by Wednesday, May 31, 2023. Upon completion of the CME/CE evaluation, attendees can download their Session 5 certificate.

For Pharmacists: Pharmacists have until the May 31 deadline to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required. Expect credit uploads to be completed within 5-7 business days after the evaluation deadline. For questions regarding the evaluation, please contact: cmhc_eval@

Information on planner and faculty disclosures can be found here.

PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Available Credit

  • 9.25 ACPE Pharmacy
  • 9.25 AMA PRA Category 1 Credit
  • 9.25 ANCC
  • 9.25 CDE
  • 9.25 Participation
Please login or register to take this course.

The evaluation will be assessible immediately after the meeting (3:00 pm EDT) on Saturday, May 20, 2023.  Evaluations must be completed by Wednesday, May 31, 2023 at 11:59 pm EDT. Upon completion of the CME/CE evaluation, attendees can download their Session 5 certificate.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.